Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 (ROCKIT-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04734379
Recruitment Status : Recruiting
First Posted : February 2, 2021
Last Update Posted : July 12, 2021
Sponsor:
Information provided by (Responsible Party):
Woolsey Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 30, 2022
Estimated Study Completion Date : July 30, 2022